Skip to main content

Department

Toxicology

Preferred Sample Type

Dosulepin (Dothiepin)

Suitable Specimen Types

  • Serum
  • EDTA Plasma
  • Li Hep Plasma
A minimum of 500 µl of plasma/serum is required.

Specimen Transport

First class post

Sample Processing in Laboratory

Place sample in toxicology rack.

Sample Preparation

None required

Turnaround Time

3 days.

Sample Stability

Keep refrigerated. 4 degrees.

Dosulepin (Dothiepin)

General Information

Dosulepin (dothiepin) is a tricyclic antidepressant, structurally related to amitriptylline and doxepin, that has been in clinical use since 1963. Single oral doses of 25 - 100 mg are administered 2 - 3 times per day, daily doses may range from 75 - 300 mg. 

Adverse effects of dosulepin therapy include dry mouth, visual disturbances, constipation, urinary retention, drowsiness, postural hypotension, tachycardia and cholestatic jaundice.

Patient Preparation

For TDM, sample should be taken prior to dose. If toxicity is suspected, take sample at earliest opportunity

Notes

Dosulepin measured by HPLC-DAD.

Serum from gel tubes (yellow top) will NOT be analysed.

Please note this assay is not currently UKAS accredited

Reference Range

High dose therapeutic use of Dosulepin (Dothiepin) associated with concentrations of up to 0.4 mg/L. Toxicity associated with concentrations > 0.8 mg/L.  (Schulz et al. Critical Care 2012, 16:R136)

Specifications

  • EQA Scheme?: Yes
  • EQA Status: LGC QUARTZ, LGC CLIN TOX